NATIONAL RESEARCH CORPNRCEarnings & Financial Report
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
NRC Q4 FY2025 Key Financial Metrics
Revenue
$35.2M
Gross Profit
N/A
Operating Profit
$4.7M
Net Profit
$1.8M
Gross Margin
N/A
Operating Margin
13.3%
Net Margin
5.1%
YoY Growth
-4.6%
EPS
$49.58
NATIONAL RESEARCH CORP Q4 FY2025 Financial Summary
NATIONAL RESEARCH CORP reported revenue of $35.2M (down 4.6% YoY) for Q4 FY2025, with a net profit of $1.8M (down 72.6% YoY) (5.1% margin).
Key Financial Metrics
| Total Revenue | $35.2M |
|---|---|
| Net Profit | $1.8M |
| Gross Margin | N/A |
| Operating Margin | 13.3% |
| Report Period | Q4 FY2025 |
NATIONAL RESEARCH CORP Annual Revenue by Year
NATIONAL RESEARCH CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $137.4M).
NATIONAL RESEARCH CORP Quarterly Revenue & Net Profit History
NATIONAL RESEARCH CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $35.2M | -4.6% | $1.8M | 5.1% |
| Q3 FY2025 | $34.6M | -3.4% | $4.1M | 11.9% |
| Q2 FY2025 | $34.0M | -2.8% | $-106.0K | -0.3% |
| Q1 FY2025 | $33.6M | -5.0% | $5.8M | 17.2% |
| Q4 FY2024 | $36.9M | -2.9% | $6.6M | 17.8% |
| Q3 FY2024 | $35.8M | -5.6% | $5.7M | 15.9% |
| Q2 FY2024 | $35.0M | -3.2% | $6.2M | 17.6% |
| Q1 FY2024 | $35.3M | -3.2% | $6.4M | 18.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.3M | $35.0M | $35.8M | $36.9M | $33.6M | $34.0M | $34.6M | $35.2M |
| YoY Growth | -3.2% | -3.2% | -5.6% | -2.9% | -5.0% | -2.8% | -3.4% | -4.6% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $120.9M | $119.1M | $131.8M | $132.5M | $135.2M | $141.4M | $135.7M | $134.9M |
| Liabilities | $84.0M | $78.9M | $97.2M | $101.3M | $105.5M | $120.1M | $121.4M | $120.9M |
| Equity | $36.9M | $40.2M | $34.6M | $31.3M | $29.7M | $21.3M | $14.3M | $14.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $12.0M | $6.8M | $9.4M | $6.4M | $6.6M | $-1.1M | $13.8M | $7.2M |